Evidence map›Paper›PMID 38341161›Full record

ArticleBioorganic & medicinal chemistry letters2024

Cytotoxic leuconoxine-type diazaspiroindole alkaloids isolated from Cryptolepis dubia.

Yulin Ren, Elizabeth N Kaweesa, Joshua M Henkin, Kongmany Sydara, Mouachanh Xayvue, Pankaj Pandey, Amar G Chittiboyina, Zulfiqar Ali, Daneel Ferreira, Djaja D Soejarto and 2 more

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yulin RenDivision of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, United States.
Elizabeth N KaweesaDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, United States.
Joshua M HenkinDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, United States.
Kongmany SydaraInstitute of Traditional Medicine, Ministry of Health, Vientiane, Lao Democratic People's Republic.
Mouachanh XayvueInstitute of Traditional Medicine, Ministry of Health, Vientiane, Lao Democratic People's Republic.
Pankaj PandeyNational Center for Natural Products Research, University of Mississippi, University, MS 38677, United States.
Amar G ChittiboyinaNational Center for Natural Products Research, University of Mississippi, University, MS 38677, United States.
Zulfiqar AliNational Center for Natural Products Research, University of Mississippi, University, MS 38677, United States.
Daneel FerreiraNational Center for Natural Products Research, University of Mississippi, University, MS 38677, United States; Division of Pharmacognosy, Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, United States.
Djaja D SoejartoDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, United States; Science and Education, Field Museum of Natural History, Chicago, IL 60605, United States.
Joanna E BurdetteDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, United States.
A Douglas KinghornDivision of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, United States. Electronic address: kinghorn.4@osu.edu.

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Project 3:Isolation Chemistry of Filamentous Fungi and Biological EvaluationP01CA125066 · NCI · OHIO STATE UNIVERSITY · PI Alan Douglas Kinghorn · 2007 to 2026
$27.2M
IRACDA at University of Illinois at ChicagoK12GM139186 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BURDETTE, JOANNA E, NONN, LARISA · 2020 to 2024
$3.6M
NCI NIH HHS P01 CA125066NCI NIH HHS P30 CA016058NIGMS NIH HHS K12 GM139186
6 · The paper itself

Abstract

Two leuconoxine-type diazaspiroindole alkaloids, the known compound, (+)-melodinine E (1), and its new analogue, (+)-11-chloromelodinine E (2), were isolated from the stems of Cryptolepis dubia (Burm.f.) M.R. Almeida (Apocynaceae), collected in Laos. The chemical structures of these compounds were determined by analysis of their spectroscopic data and by comparison of these data with literature values, of which the molecular structure of 1 has been determined previously by analysis of its single-crystal X-ray diffraction data. The absolute configurations of 1 and 2 have been defined by their experimental and simulated electronic circular dichroism (ECD) spectroscopic data and supported by

Indexed as

Antineoplastic AgentsIndole AlkaloidsOvarian NeoplasmsApoptosisCell Line, TumorCryptolepisFemaleHumansMolecular StructureAntineoplastic AgentsIndole AlkaloidsleuconoxineAbsolute configurationCryptolepis dubiaLeuconoxine-type diazaspiroindole alkaloidsMelodinine ESelective cytotoxicity

Identifiers

PMID38341161
PMCPMC11034800

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.